Shu Jiang, also known as Joy Jiang, is a Canadian biostatistician and tenured associate professor in the Division of Public Health Sciences at the Washington University School of Medicine in St. Louis. In August 2026, the University of Toronto announced that Jiang will serve as the Eddie Goldenberg Research Chair of Canada in 2027. She co-founded Prognosia Inc. with Graham Colditz, a technology company that develops AI models that assess digital mammograms to accurately predict the risk of breast cancer. Prognosia's first tool, Prognosia Breast, earned Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) in June 2025, and the company was acquired by Lunit in September 2025.
- Occupation
- biostatistician
- Website
- https://www.shujoyjiang.com/about
